Compare EVO & ASIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVO | ASIC |
|---|---|---|
| Founded | 1993 | 2018 |
| Country | Germany | United States |
| Employees | 4553 | 203 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 934.1M | 930.6M |
| IPO Year | N/A | N/A |
| Metric | EVO | ASIC |
|---|---|---|
| Price | $3.00 | $20.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $7.00 | ★ $26.75 |
| AVG Volume (30 Days) | ★ 107.1K | 49.5K |
| Earning Date | 04-08-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.37 | $34.21 |
| Revenue Next Year | $10.05 | $34.65 |
| P/E Ratio | ★ N/A | $98.60 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.31 | $16.35 |
| 52 Week High | $4.80 | $23.88 |
| Indicator | EVO | ASIC |
|---|---|---|
| Relative Strength Index (RSI) | 51.88 | 45.68 |
| Support Level | $2.87 | $19.49 |
| Resistance Level | $3.78 | $20.67 |
| Average True Range (ATR) | 0.10 | 0.58 |
| MACD | 0.02 | -0.07 |
| Stochastic Oscillator | 50.00 | 0.00 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Ategrity Specialty Insurance Co Holdings is a specialty property and casualty insurance holding company focused on the excess and surplus market for small to medium-sized businesses (SMBs) across the United States. Operating through its subsidiaries, the company underwrites small and medium-sized commercial risks across selected industry verticals, including Retail, Real Estate, Hospitality, and Construction. Its operating model uses a technology-driven method to standardize, simplify, and, where appropriate, automate these transactions. The group distributes its products through licensed surplus lines brokers and wholesale agents.